Literature DB >> 1612325

Excessive production of reactive oxygen metabolites by inflamed colon: analysis by chemiluminescence probe.

A Keshavarzian1, S Sedghi, J Kanofsky, T List, C Robinson, C Ibrahim, D Winship.   

Abstract

Reactive oxygen metabolites (ROMs) are involved in inflammatory diseases and are postulated to contribute to tissue injury in colitis. To determine whether excessive ROMs are generated by inflamed colonic mucosa and to identify possible sources and type of ROMs, mucosal ROMs were estimated in rats and humans using a chemiluminescence probe. Colitis was induced in rats by intracolonic injection of acetic acid or intraperitoneal injection of mitomycin C. Intact, inflamed colon in rats produced more ultraweak chemiluminescence than normal colon. Inflamed mucosal scrapings from both rat models produced significantly more luminol-enhanced chemiluminescence. Addition of catalase, an H2O2 scavenger, or azide, a myeloperoxidase inhibitor, into the media significantly decreased chemiluminescence from inflamed mucosal scrapings. Indomethacin, an antioxidant cyclo-oxygenase inhibitor, also decreased chemiluminescence, but MK-866, a 5-lipoxygenase inhibitor, had no effect. Colonic biopsy specimens obtained during colonoscopy from patients with ulcerative colitis also produced more catalase-inhibitable chemiluminescence than normal colonic mucosa. These data indicate that excessive ROMs are produced by inflamed colonic mucosa in both humans and rats, which may contribute to tissue injury.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1612325     DOI: 10.1016/0016-5085(92)91111-g

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  65 in total

1.  Carbonylation and disassembly of the F-actin cytoskeleton in oxidant induced barrier dysfunction and its prevention by epidermal growth factor and transforming growth factor alpha in a human colonic cell line.

Authors:  A Banan; Y Zhang; J Losurdo; A Keshavarzian
Journal:  Gut       Date:  2000-06       Impact factor: 23.059

2.  Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease.

Authors:  A Keshavarzian; A Banan; A Farhadi; S Komanduri; E Mutlu; Y Zhang; J Z Fields
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

3.  Direct evidence of oxidative damage in acute and chronic phases of experimental colitis in rats.

Authors:  C Loguercio; G D'Argenio; M Delle Cave; V Cosenza; N Della Valle; G Mazzacca; C del Vecchio Blanco
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

4.  Sucralfate prevents the delay of wound repair in intestinal epithelial cells by hydrogen peroxide through NF-kappaB pathway.

Authors:  Kenichi Shindo; Masahiro Iizuka; Kenji Sasaki; Shiho Konno; Hiroaki Itou; Yasuo Horie; Sumio Watanabe
Journal:  J Gastroenterol       Date:  2006-05       Impact factor: 7.527

5.  Protective effects of citicoline on TNBS-induced experimental colitis in rats.

Authors:  Rauf Onur Ek; Mukadder Serter; Kemal Ergin; Serpil Cecen; Cengiz Unsal; Yuksel Yildiz; Mehmet D Bilgin
Journal:  Int J Clin Exp Med       Date:  2014-04-15

6.  Decreased total and corrected antioxidant capacity in patients with inflammatory bowel disease.

Authors:  Ioannis E Koutroubakis; Niki Malliaraki; Philippos D Dimoulios; Konstantinos Karmiris; Elias Castanas; Elias A Kouroumalis
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

7.  Prophylactic administration of topical glutamine enhances the capability of the rat colon to resist inflammatory damage.

Authors:  Eran Israeli; Eduard Berenshtein; Dov Wengrower; Larisa Aptekar; Ron Kohen; Gershom Zajicek; Eran Goldin
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

8.  Up-regulation of mitochondrial chaperone TRAP1 in ulcerative colitis associated colorectal cancer.

Authors:  Ru Chen; Sheng Pan; Keith Lai; Lisa A Lai; David A Crispin; Mary P Bronner; Teresa A Brentnall
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

9.  Nrf2 is not required for epithelial prohibitin-dependent attenuation of experimental colitis.

Authors:  Arwa S Kathiria; Mackenzie A Butcher; Jason M Hansen; Arianne L Theiss
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-03-14       Impact factor: 4.052

10.  Increased production of luminol enhanced chemiluminescence by the inflamed colonic mucosa in patients with ulcerative colitis.

Authors:  S Sedghi; J Z Fields; M Klamut; G Urban; M Durkin; D Winship; D Fretland; M Olyaee; A Keshavarzian
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.